Lexaria Bioscience Corp. (LEXX)
3.08
+0.09
(+3.01%)
USD |
NASDAQ |
Oct 23, 16:00
3.00
-0.08
(-2.60%)
After-Hours: 20:00
Lexaria Bioscience Market Cap : 5.090M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 5.090M |
| October 22, 2026 | 4.941M |
| October 21, 2026 | 4.66M |
| October 20, 2026 | 4.379M |
| October 19, 2026 | 4.296M |
| October 16, 2026 | 4.726M |
| October 15, 2026 | 4.941M |
| October 14, 2026 | 4.66M |
| October 13, 2026 | 4.627M |
| October 12, 2026 | 5.404M |
| October 09, 2026 | 5.486M |
| October 08, 2026 | 5.288M |
| October 07, 2026 | 5.718M |
| October 06, 2026 | 5.354M |
| October 05, 2026 | 4.577M |
| October 02, 2026 | 4.759M |
| October 01, 2026 | 5.106M |
| September 30, 2026 | 5.205M |
| September 29, 2026 | 5.172M |
| September 28, 2026 | 5.329M |
| September 25, 2026 | 5.420M |
| September 24, 2026 | 5.569M |
| September 23, 2026 | 5.346M |
| September 22, 2026 | 5.321M |
| September 21, 2026 | 5.660M |
| Date | Value |
|---|---|
| September 18, 2026 | 5.354M |
| September 17, 2026 | 5.437M |
| September 16, 2026 | 5.114M |
| September 15, 2026 | 5.304M |
| September 14, 2026 | 5.866M |
| September 11, 2026 | 6.560M |
| September 10, 2026 | 6.693M |
| September 09, 2026 | 10.91M |
| September 08, 2026 | 15.48M |
| September 04, 2026 | 23.38M |
| September 03, 2026 | 20.36M |
| September 02, 2026 | 21.82M |
| September 01, 2026 | 20.61M |
| August 31, 2026 | 18.64M |
| August 28, 2026 | 17.10M |
| August 27, 2026 | 19.30M |
| August 26, 2026 | 18.24M |
| August 25, 2026 | 19.17M |
| August 24, 2026 | 17.42M |
| August 21, 2026 | 18.04M |
| August 20, 2026 | 18.62M |
| August 19, 2026 | 19.02M |
| August 18, 2026 | 19.04M |
| August 17, 2026 | 17.05M |
| August 14, 2026 | 14.94M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Target Group, Inc. (Canada) | 0.617M |
| InMed Pharmaceuticals, Inc. | 7.689M |
| XORTX Therapeutics, Inc. | 1.592M |
| NervGen Pharma Corp. | 152.17M |
| Milestone Pharmaceuticals, Inc. | 80.70M |
Market Cap Related Metrics
| PS Ratio | 23.86 |
| Price to Book Value | 1.074 |
| Price | 3.08 |
| Earnings Yield | -171.4% |